Radiotherapy risks are much higher for smokers

March 20, 2017

Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy - according to a new study funded by Cancer Research UK and published today in the Journal of Clinical Oncology.

The study shows that for non-smokers the long-term risk of death from or - caused by radiation - is only 0.5 percent. But for smokers, this increases to around 5 percent.

These findings are based on a worldwide study by the Early Breast Cancer Trialists' Collaborative Group of the lung and heart radiation doses and risks among 40,781 women with in 75 randomised trials of radiotherapy.

Because modern breast radiotherapy techniques have improved and are now better at sparing the lungs and heart than those used in the trials, the researchers also reviewed recent literature so they could take into account how radiotherapy is better targeted today.

Dr Carolyn Taylor, radiation oncologist and lead author from the University of Oxford, said: "For non-smokers, the absolute risk of death from the side effects of modern radiotherapy is only about 0.5 percent, which is much less than the benefit. But for smokers, the risk is about 5 percent, which is comparable with the benefit.

"Stopping smoking at the time of radiotherapy will avoid most of the lung cancer and heart disease risk from radiotherapy, and has many other benefits."

Radiotherapy remains an important treatment for breast cancer and reduces the likelihood of dying from the disease. For most non-smokers or ex-smokers the benefits of radiotherapy will far outweigh any risks. But for some long-term continuing smokers, the risks may be greater than the benefits.

Dr Julie Sharp, Cancer Research UK's head of health information, said: "This research highlights that who smoke need to be offered help and support in order to try and quit to minimise any risks from their treatment. It's important to remember that modern day techniques have been refined and improved to make sure it is targeted and effective while reducing the risk of side-effects."

Explore further: Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer

More information: Taylor, C., et al Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials Journal of Clinical Oncology (2017) DOI: 10.1200/JCO.2016.72.0722

Related Stories

Smoking can hamper common treatment for breast cancer

June 17, 2016

We know that individuals who smoke take major health risks. Now a new research study from Lund University in Sweden shows that common treatment for breast cancer works less well in patients who smoke, compared to non-smokers.

Recommended for you

Targeted drug shows promise in rare advanced kidney cancer

June 23, 2017

Some patients with a form of advanced kidney cancer that carries a poor prognosis benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by a Dana-Farber ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.